EP3523624A1 - Procédé et dispositif de préparation d'échantillons - Google Patents
Procédé et dispositif de préparation d'échantillonsInfo
- Publication number
- EP3523624A1 EP3523624A1 EP17794362.8A EP17794362A EP3523624A1 EP 3523624 A1 EP3523624 A1 EP 3523624A1 EP 17794362 A EP17794362 A EP 17794362A EP 3523624 A1 EP3523624 A1 EP 3523624A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- sample
- capture
- concentration
- container
- cartridge
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/04—Cell isolation or sorting
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/14—Bags
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/26—Constructional details, e.g. recesses, hinges flexible
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/06—Hydrolysis; Cell lysis; Extraction of intracellular or cell wall material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/10—Separation or concentration of fermentation products
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/24—Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/405—Concentrating samples by adsorption or absorption
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/4005—Concentrating samples by transferring a selected component through a membrane
Definitions
- the present invention relates generally to sample preparation for the purpose of capturing and concentrating microorganism or protein derived from said microorganism.
- the field of application of the invention is that of microbiology and more particularly that of industrial microbiology.
- Raw products used and processed products marketed by the food industry are subject to many microbiological tests to ensure their safety (absence of pathogenic bacteria or degradation, absence of bacteria markers of contamination dangerous to health, absence of toxins).
- pathogenic microorganisms such as Salmonella or E. Coli 0157: H7 strain
- their toxins the research of which applies to raw materials, intermediate products, finished products marketed
- the microbiological analysis generally involves one or more pre-enrichment and / or enrichment phases, one or more detection phases, one or more enumeration phases of the microorganisms.
- a confirmation phase may also be required to meet the standards in force in this area.
- the detection phase is historically based on the growth (culture) of microorganisms on essentially agaric media, and by the demonstration of the metabolic characteristics of the microorganisms sought.
- Typical enzyme substrates are conventionally used. These substrates can be compounds used in bacterial metabolism and leading to a modification of the medium detected by indicators (pH variation, reduction, precipitation, etc.).
- these enzymatic substrates are composed of two parts, a first specific part of the enzymatic activity to be revealed, also called target part, and a second part serving as a marker, called a marker part, generally constituted by a chromophore or a fluorophore.
- chromogenic media enables the simultaneous detection and identification of the desired microorganisms. It simplifies the process and significantly reduces the time to get the result.
- ChromlD ® media of the applicant These chromogenic media are based on the detection of specific metabolic characteristics of the desired seeds, for example the enzymatic activity beta-glucuronidase for Escherichia coli.
- Immunoassays are another technology used for the detection test. They use the immunogenic characteristics of micro-organisms research. Non-exhaustively, there may be mentioned ELIS A (Enzyme Linked Immuno Sorbent Assay), by competition or sandwich type.
- molecular biology techniques based on the genomic characteristics of the microorganisms sought, are also used to detect and identify target microorganisms. These molecular biology techniques offer extremely interesting perspectives. By way of example, mention may be made of conventional amplification techniques such as PCR ("Polymerase Chain Reaction” in English) and NASBA ("Nucleic Acid Sequence Based Amplification” in English), which can be coupled with real-time detection known to those skilled in the art.
- PCR Polymerase Chain Reaction
- NASBA Nucleic Acid Sequence Based Amplification
- the confirmation phase is sometimes necessary to confirm the presence of the pathogen sought, when the result of the previously developed methods is positive. This imposes a complementary test and the use of a detection principle different from that used during the first analysis. The techniques described above are used at leisure for confirmation.
- the detection phase is generally preceded by at least one pre-enrichment and / or enrichment phase (more generally referred to as phase or enrichment step for the purposes of the present application).
- phase or enrichment step for the purposes of the present application.
- the latter is essential insofar as, at present, there is no method for detecting a target microorganism in a biological sample, present in a minimal amount, for example of the order of a few cells in the sample, without resorting to a prior stage of enrichment.
- This enrichment phase requires the use of culture media, selective or not (depending on the purpose), which aims to promote the growth of target microorganisms in biological or environmental samples, while limiting growth. non-target flora.
- the culture media are frequently used in containers of the sterile plastic bag type, in which they are brought into contact with food or environmental samples, for the purpose of resuspension and enrichment of the desired microorganisms.
- this enrichment phase is necessary in particular in order to reveal the presence of at least one target microorganism in a very variable and possibly very large sample quantity, for example from 25 g (g) to 375 g. diluted in a volume of culture medium of between 225 and 3375 milliliters (mL).
- an aliquot generally of a volume between 5 microliters ( ⁇ ) and 5 ml
- the concentration of target microorganisms in some cases remains insufficient and / or the concentration of the annexed flora remains too important to perform an effective detection of target microorganisms.
- those skilled in the art generally use sample processing methods whose objective is to increase the ratio between the concentration of target microorganisms and the concentration of the annexed flora. For example, after enrichment, a fraction of the sample (preferably between 1 and 10 ml) is treated by an immuno-concentration method using magnetic beads functionalized with antibodies specific for the target microorganisms.
- the enrichment step requires not only an ad hoc culture medium but also an incubation of the assembly formed at least by the biological sample and the culture medium at an optimal temperature to allow the growth of the microorganism (s) target (s).
- Incubation is generally carried out at a temperature ranging from 25 to 45 ° C. for a predetermined period of time (for example from 6 to 48 hours). During this incubation period, no additional action is performed on the sample. This time is not used, it is somehow "lost". However, this goes against the problem presented above, aiming at developing a precise and rapid analysis technique. Indeed, during this enrichment step, the sample is immobilized in an oven without intervention means because this step is generally performed during the night.
- one of the objectives of the present invention is to improve the capture and / or concentration of target microorganisms (of interest) or proteins derived from said microorganisms by increasing the contact time with a capture medium and / or concentration.
- Another object of the present invention is to control the volume of sample in contact with the binding partners of the capture medium, the contact time of the sample with these binding partners and therefore the flow rate of the sample through the capture medium. This new technique thus makes it possible to optimize the reaction conditions of the binding partners with the microorganisms or proteins derived from these microorganisms contained in the sample.
- Another object of the present invention is to propose a treatment of the sample (preferably automatically) on a large volume of sample and not only on an aliquot, said treatment consisting in capturing and concentrating the target microorganisms (d). interest) or proteins derived from said microorganisms to improve the sensitivity and specificity of the detection method used post-treatment.
- the invention also aims to enhance / optimize the incubation time during the enrichment phase of the biological sample by performing, during the incubation period / enrichment and growth of microorganisms, a capture and / or or a concentration of target microorganisms present in the sample (preferably in an automated manner).
- Another object of the present invention is to provide a method for increasing the rate of sample analysis and / or reducing the total time required for the analysis of the biological sample.
- Another object of the present invention is to limit the handling of the sample contained in the container, thereby limiting the risk of contamination, either the personnel handling the sample or the sample itself.
- the present invention also relates to the development of a method for preparing an automated or semi-automated sample.
- Another object of the present invention is to improve the traceability of the analysis due to the drastic reduction of the sample handling steps. Other objectives will appear on reading the present application.
- the present invention therefore aims to achieve all or part of the aforementioned objectives.
- the container used for the purpose of the present invention comprises:
- a device for capturing and / or concentration of microorganism or protein derived from said microorganism comprising a capture and / or concentration support,
- a container comprising at least two walls, at least one of which is flexible, adapted to receive at least one sample capable of containing at least one target microorganism, said container comprising an inlet port moved through one of said walls and allowing the passage of the sample contained in the container towards the capture and / or concentration device
- an input fluidic guide capable of containing a defined sample volume and making it possible to guide said volume of sample towards said inlet orifice
- said capture and / or concentration device being attached to a wall of the container.
- the container comprises a device for capturing and / or concentration of microorganism or protein derived from said microorganism, comprising a capture and / or concentration support.
- the capture and / or concentration device is partially attached to the outer face of one of said walls of the container.
- the container comprises at least two sealed connectors adapted to the inlet and outlet ports of the container. The sealed connectors then prevent the sample from spreading out of the container and thus contaminate the environment or the technician handling the sample.
- the capture / concentration device may be in the form of a cartridge attached to the container.
- the capture and / or concentration device can be detached from the wall of said container.
- the capture / concentration device is composed of two parts:
- a first part corresponding to a cartridge holder which can be attached to the wall of the container and a second portion corresponding to the cartridge comprising the capture medium.
- the present invention relates to a container as described above characterized in that the device for capturing and / or concentration of microorganism or protein derived from said microorganism comprises
- a cartridge holder comprising:
- At least one insertion means allowing a cartridge to be inserted into the cartridge holder
- first intake duct allowing entry of a liquid sample; the first intake duct being connected to an inlet duct of the cartridge when the cartridge holder and the cartridge are positioned in a so-called "capture / concentration" fluid path,
- At least one second intake duct allowing the entry of a washing liquid and / or a lysis liquid and / or an elution liquid; the second intake duct being connected to an intake duct of the cartridge when the cartridge holder and the cartridge are positioned in a fluidic pathway called "lysis and / or washing and / or elution", at least one duct evacuation device allowing the exit of the liquid sample and / or the washing, lysis or elution liquid; the evacuation duct being in connection with the escape route of the cartridge.
- a cartridge comprising:
- At least one insertion means allowing the cartridge to be inserted into at least two different positions, a first position along a so-called “capture / concentration” fluidic path and a second position along a fluidic path called "lysis and / / or washing and / or elution ", - a reaction module comprising
- a capture and / or concentration support disposed between the intake path and the evacuation path such that all or part of the sample or liquids passes through it;
- the cartridge may comprise a cover and a bottom assembled by clipping, gluing, welding, riveting, riveting, crimping, or any other means allowing a reliable and resistant assembly.
- the seal between the lid and the bottom of the cartridge can be achieved by simple gluing. It can also be achieved by adding an adhesive, silicone, putty between the ad hoc faces of the cover and the bottom of the cartridge. It can also be achieved by means of a seal and counter-joint.
- the capture medium is disposed within the reaction module of the cartridge.
- the cartridge and the cartridge holder comprise an insertion means.
- the term "insertion means" means any means for guiding the cartridge in the cartridge holder. It can, for example, be slides.
- the insertion means contains a polarizer, for example an asymmetric slide, for guiding the cartridge in the cartridge holder in one direction.
- the device is attached to a wall of a container adapted to receive a sample.
- the cartridge holder and / or the cartridge can (can) be separated from the wall of said container.
- a base is contiguous to the internal face of the wall of the container and comprises
- the cartridge, the cartridge holder and the base may be made of a plastic material, for example they may be injected into a polymer of the class of polyolefins, or polyamides, or polyesters (non-limiting). Some biobased materials can also be considered.
- the base is connected to a fluid guide allowing the sample contained in the container to reach the intake channel of the base.
- the container used for the purposes of the present invention comprises an open or closed container (for example hermetically sealed or sealed) comprising at least two walls, at least one of which is flexible.
- the container is a bag having a flexible envelope of the homogenization bag type.
- at least one wall of the container is transparent in order to be able to perceive the volume occupied by the liquid inside the container.
- the container comprises an inlet fluid guide, capable of containing a defined sample volume and for guiding said sample volume to said inlet port.
- the fluid guide may be constituted by any means for guiding the biological sample contained in the container to the inlet port of the capture / concentration device.
- the fluid guide is elastic and intended to be pressed. It may be a silicone tube for example.
- the fluidic guide is an internal pocket of the container to be pressed.
- at least a portion of the inner bag is a part of the flexible wall of the container.
- the fluid guide may be constituted by any means for guiding the biological sample contained in the container to the intake channel of the base.
- the fluid guide is elastic and intended to be pressed. It may be a silicone tube for example.
- the container may comprise an outlet fluid guide for fluid communication between the outlet orifice of the capture and / or concentration device and the container.
- the fluid guide may optionally be provided with a vent system preventing the walls of the container from sticking together and obstruct the passage to the capture device and / or concentration.
- the container comprises means for controlling the volume of sample transferred from the fluid guide to the capture device and / or concentration through said inlet port.
- the volume control means is a section of a determined diameter of the fluid guide and the size (length) of the fluid guide.
- the container may comprise a compartment for receiving the filtrate of the sample, a filter separating said container into two compartments, one serving to receive the sample, the other serving to receive the filtered sample.
- the fluidic guide comprises a filter preventing the capture medium from being obstructed with certain samples.
- the inlet can be located in the lower part and the exit in the upper part.
- the flow of the sample through the capture / concentration medium is from bottom to top.
- the inlet port may be located in the upper part and the outlet port in the lower part. In this case, the flow of the sample through the capture / concentration medium will be gravitational from top to bottom.
- the way inlet and the first intake duct of the sample may be located in the lower part and the escape route and the exhaust duct in the upper part.
- the flow of the sample through the capture / concentration medium is from bottom to top.
- the intake channel and the first intake duct may be located in the upper part and the duct and the exhaust duct in the lower part. In this case, the flow of the sample through the capture / concentration medium will be by gravity from top to bottom.
- the capture and / or concentration device comprises a means for recovering the nucleic acids once the microorganisms have been lysed by the lysis liquid, able to be placed in fluid communication with the second conduit. admission of the cartridge holder.
- the sample may be of various origins, for example of food, environmental, veterinary or clinical origin.
- samples of food origin there may be mentioned, non-exhaustively, a sample of dairy products (yogurt, cheese ...), meat, fish, egg, fruit, vegetable, water, drink (milk, fruit juice, soda, etc.).
- dairy products dairy products
- cheese meat, fish, egg, fruit, vegetable, water, drink
- drink milk, fruit juice, soda, etc.
- these food-based samples may also come from sauces or more elaborate dishes or non-(or partially) processed raw materials.
- a food sample may finally be derived from a feed intended for animals, such as cakes, animal meal.
- samples include samples related to the environment such as surface, water, air, etc. samples.
- Clinical samples may be samples of biological fluids (whole blood, serum, plasma, urine, cerebrospinal fluid, etc.), stool, nasal specimens, throat, skin, wounds, organs, tissues or isolated cells. This list is obviously not exhaustive.
- sample refers to a part or quantity (more particularly a small part or a small quantity) taken from one or more entities for analysis.
- This sample may have undergone a prior treatment, involving, for example, mixing, dilution and further grinding steps, in particular if the starting entity is in the solid state, or pre-enrichment or enrichment by contacting with a culture medium . It can also be filtered beforehand or within the container itself or the capture / concentration device. The sample is therefore in liquid form during the process according to the present invention.
- the sample in addition to the culture medium may, of course, comprise additional elements, such as vitamins or other nutrients useful for culturing microorganisms, selective agents, specific substrates and other well-known elements of the invention. skilled person.
- the sample analyzed is, in general, likely to - or suspected of - containing at least one target microorganism. In most cases, the latter is a pathogenic micro-organism (such as Salmonella) that should be detected for health purposes.
- a pathogenic micro-organism such as Salmonella
- micro-organism has the same meaning as that generally accepted in microbiology and particularly includes gram-positive or gram-negative bacteria, yeasts, molds and, more generally, unicellular organisms, invisible to the naked eye, which can be manipulated and multiplied in the laboratory.
- the microorganism (s) to be detected are bacteria, for example enterobacteria such as E. Coli.
- the present invention also applies to the capture and / or concentration of protein (s) derived from said microorganism such as toxins.
- s protein derived from said microorganism
- the detection of toxins secreted by Staphylococcus aureus may be mentioned.
- the sample comprises at least one culture medium for the growth of microorganisms and, in particular, of the target microorganism (s).
- culture medium is meant a medium comprising all the elements necessary for the survival and / or growth of the micro-organisms and, in particular, the microorganisms sought (for example peptone-buffered water).
- the culture medium may contain any additives, for example: peptones, one or more growth factors, carbohydrates, one or more selective agents, buffers, one or more gelling agents, one or more vitamins, etc.
- This culture medium may be in liquid or gel form ready for use, namely ready to be seeded in a tube, in a bottle or on a petri dish.
- the expression "culture medium” obviously includes enrichment media and broths.
- capture medium and / or concentration is meant any support for fixing the microorganism or the protein of said microorganism sought (e) and ensure that it (it) is in sufficient concentration for the purposes of subsequent steps analysis.
- the "capture and / or concentration medium” will also be referred to indifferently as “capture / concentration support”.
- the "capture and / or concentration support” is chosen from particulate supports or monoblock supports.
- the capture / concentration support may be particles.
- the capture and / or concentration support is a porous capture and / or concentration support. Preferably, it is a porous membrane.
- the capture and / or concentration support is functionalized with at least one specific binding partner of the target microorganism or of protein derived from said microorganism.
- the specific binding partner is selected from the group comprising antibodies, Fab fragments, Fab 'fragments, recombinant or non-recombinant phage proteins, phages or any other ligand well-known to humans. of career.
- the analysis can be performed in situ from the capture and concentration support.
- the revelation of the presence of the target microorganisms at the level of the capture and concentration support can be carried out by means of any appropriate revelation system, ie capable of allowing the detection of the microorganism (s). ⁇ ) target (s).
- revealing system any molecule capable of coupling with the microorganisms or binding partners of said microorganisms by allowing, by their transduction properties (fluorescence, coloration, radioactivity, etc.), to reveal the presence of said microorganisms.
- This revelation of the presence of the target microorganisms can be obtained in particular by visualization (with the naked eye) or optical reading (via a camera-type optical reading device) of a staining (such as red staining due to formazan TTC reduction by microorganisms) or fluorescence on all or part of the capture medium.
- the analysis can be carried out by any detection means, said detection means being selectable from optical detection means, electrical detection means (in particular electrochemical), acoustic detection means, means for detecting thermal detection means, the mechanical detection means, the magnetic detection means.
- detection means being selectable from optical detection means, electrical detection means (in particular electrochemical), acoustic detection means, means for detecting thermal detection means, the mechanical detection means, the magnetic detection means.
- the present invention also relates to the use of the container for capturing and concentrating a microorganism or a protein derived from said microorganism included in a sample.
- the container may be disposed in a device comprising at least one location for receiving said container, said device comprising
- At least one pressure means on the fluidic guide in order to trap a determined volume of sample in the fluid guide
- the displacement of the sample can be exercised manually or mechanically.
- a device is described in the patent application WO2014072438 filed by the applicant. It may be a device with blades (or arm), said blades from compressing the flexible wall container (for example plastic PVC, polyethylene, polyester). This device allows optimal control of the flow rate of the sample in the capture / concentration medium.
- the pressure means can be, meanwhile, any means for gripping the fluid guide, preventing the sample outside the fluid guide to return inside the fluid guide.
- the present invention also relates to the development of a method for preparing a sample capable of containing at least one target micro-organism essentially comprising the following steps:
- a device for capturing and / or concentrating the target microorganism or protein derived from said microorganism comprising a capture and / or concentration support;
- a container with at least two walls, at least one of which is flexible, adapted to receive said sample that may contain at least one target microorganism, said container comprising
- an inlet port moved through one of said walls and allowing the passage of the liquid sample contained in the container towards the capture and / or concentration device
- an input fluidic guide capable of containing a defined sample volume and making it possible to guide said volume of sample towards said inlet orifice
- said capture / concentration device was attached to a wall of the container.
- the present invention also relates to the development of a method for preparing a sample capable of containing at least one target micro-organism as described above characterized in that the capture and / or concentration device comprises
- a cartridge holder comprising:
- At least one insertion means allowing a cartridge to be inserted into the cartridge holder
- first intake duct allowing entry of a liquid sample; the first intake duct being in connection with the inlet duct of the cartridge when the cartridge holder and the cartridge are positioned in a so-called "capture / concentration" fluidic path,
- At least one second intake duct allowing the entry of a washing liquid and / or a lysis liquid and / or an elution liquid; the second intake duct being connected to an intake duct of the cartridge when the cartridge holder and the cartridge are positioned in a fluidic pathway called "lysis and / or washing and / or elution".
- At least one evacuation conduit allowing the exit of the liquid sample and / or the washing or lysing liquid to the container; the evacuation duct being in connection with the escape route of the cartridge.
- a cartridge comprising:
- At least one insertion means allowing the cartridge to be inserted into at least two different positions, a first position along a so-called “capture / concentration” fluidic path and a second position along a fluidic path called "lysis and / / or washing and / or elution.
- the displacement of the sample towards the capture and / or concentration device is carried out mechanically and repeatedly.
- Recirculation of the sample through the capture medium makes it possible to increase the contact time of the microorganism with the capture / concentration support and thus to increase the likelihood of the microorganism meeting with the capture / concentration support.
- the sample may optionally have undergone prior treatment, involving, for example, pre-enrichment or enrichment steps by contact with a culture medium.
- This step of contacting the sample with a culture medium can also be done within the container according to the invention.
- said method comprises a step of incubating said sample at a temperature and for a period of time sufficient to allow the growth of said at least one target microorganism, the incubation step taking place before step a ) or during all or some of the steps a) to d).
- the incubation time can be optimized by choosing to capture / concentrate during the incubation.
- the skilled person will know, from his experience, his general knowledge and / or bibliographic data at his disposal, adapt the temperature and the time necessary to allow sufficient growth of the microorganism target, depending on the type of microorganism sought.
- the incubation is generally carried out at a temperature ranging from 25 to 45 ° C for a predetermined period of time (for example from 6 to 48 hours) .
- the displacement of all or part of the sample towards the fluid guide and then towards the capture and / or concentration device through the inlet orifice can be obtained by any means known to those skilled in the art.
- the fluidic guide (s) allows (the) content to contact the inlet port while preventing the contents from coming into contact with the outlet port unless not passed through the capture and concentration device.
- this displacement can be generated by the application of a force or a set of forces on the container or the change in the balance of forces applying to the container.
- a force or a set of forces on the container or the change in the balance of forces applying to the container.
- the container will tilt and the level of the content will vary, at least in part. from the inner surface of the container, from the level of rest to a level above it and will possibly be brought into contact with the means for creating the inlet via the fluid guide.
- the displacement of the contents can also be achieved by applying a force or a force system inside the container, for example by inflating and deflating an inflatable flexible bag (such as a balloon or an inflatable bead) placed in the enclosure of the container.
- an inflatable flexible bag such as a balloon or an inflatable bead
- steps b) and c) are carried out using a device comprising a displacement means and a pressure means as described above, in order to exert pressure on the fluidic guide and to allow a determined volume of the sample is brought into contact with the capture medium and / or concentration.
- a device comprising a displacement means and a pressure means as described above, in order to exert pressure on the fluidic guide and to allow a determined volume of the sample is brought into contact with the capture medium and / or concentration.
- a device is described in the patent application WO2014072438 filed by the applicant. It may be a device with blades (or arm), said blades from compressing the flexible wall container (for example plastic PVC, polyethylene, polyester).
- the capture and / or concentration support is a porous membrane.
- the circulation is in tangential flow through the membrane, which has the advantage of increasing the contact time between the microorganism and the capture medium.
- all or part of the sample contained in the receptacle circulates through the capture / concentration support at a flow rate of between 0.5 ml / min per cm 2. of support at 5 mL / min per cm 2 of support, said support being porous and having a developed area of at least 20 cm 2 .
- the present invention has the advantage of allowing the capture and then the revelation of the presence of target micro-organism in a very variable and possibly very large sample quantity, for example from 25 g (g) to 375 g diluted in a volume of culture medium between 225 and 3375 mL.
- the volume of the sample that can pass through the capture / concentration device is between 10 ml and 5000 ml, preferably between 50 ml and 4000 ml, more preferably between 200 and 3500 ml, more preferably between 225 and 3375 ml. mL.
- This method advantageously makes it possible to use a large starting volume to carry out the capture / concentration, which makes it possible to increase the probability of encountering the target microorganism (or the protein resulting from this microorganism) with the capture / concentration support.
- at least 10 ml of the sample contained in the receptacle circulates through the capture medium and / or concentration, preferably at least 50 ml.
- the process for preparing a sample according to the invention is a method for capturing / concentrating at least one target microorganism of a sample that may contain said at least one target micro-organism. It is a method for allowing the capture / concentration of at least one target micro-organism, preferably in the presence of at least one culture medium / enrichment broth.
- this method allows that said at least one target micro-organism is present at the end of the process according to the invention at a concentration such that the user can possibly detect it in a systematic or quasi-systematic manner by resorting to traditional methods of detection (culture on agar media, immunoassays, molecular biology techniques, etc.).
- the present invention therefore relates to the development of a method for preparing a sample capable of containing at least one target micro-organism comprising the following steps:
- the method for preparing a sample according to the present invention also comprises one or more washing step (s) with a washing liquid dispensed in the second intake duct of the cartridge holder, the cartridge being disposed according to a fluidic pathway called lysis and / or washing and / or elution.
- a washing liquid dispensed in the second intake duct of the cartridge holder, the cartridge being disposed according to a fluidic pathway called lysis and / or washing and / or elution.
- the method for preparing a sample according to the present invention also comprises one or more lysis liquid lysis step (s) dispensed in the second intake duct of the cartridge holder, the cartridge being disposed in a fluidic pathway called lysis and / or washing and / or elution.
- the method for preparing a sample according to the present invention comprises one or more elution stage (s) with an elution liquid dispensed in the second intake duct of the cartridge holder. cartridge being disposed in a fluidic pathway called lysis and / or washing and / or elution.
- the method of preparing a sample according to the present invention comprises a subsequent step of aspirating the liquid of interest containing the nucleic acids of said microorganisms released during lysis.
- This aspiration step can be done using a syringe (which can be used to inject the washing / lysis solution) or a pipette, a vacutainer®, a psipette or a peristatic pump, connected to the second intake duct of the cartridge holder.
- the method of preparation comprises a subsequent decontamination step with a decontaminant dispensed in the second intake duct of the cartridge holder, the cartridge being disposed in a liquefied fluid pathway and / or washing and / or or elution.
- the method according to the invention makes it possible to capture and concentrate efficiently a target microorganism of a biological sample while limiting the handling of the sample contained in the container, thereby limiting the risk of contamination, ie personnel handling the sample. sample, either of the sample itself.
- the method according to the invention comprises a subsequent step of analyzing said capture medium and concentration by visual, optical or any other means.
- this method makes it possible to analyze said target microorganism (s) and / or all or part of their properties.
- the analysis can consist in particular of a method of direct detection - and possibly identification - of said microorganism (s) ⁇ ) or of a method of detection - and, where appropriate, identification - indirect, for example linked to detecting specific nucleotide and / or protein information of a type of microorganism to be detected and / or identified.
- This detection and / or indirect identification may also result from the detection of proteins specifically binding to specific bacteriophage proteins of said one or more microorganisms to detect.
- the presence of a target micro-organism can also be detected by resistance to a given antibiotic or a set of antibiotics, the resistance profile of this or these antibiotic (s) being, in this case, characteristic of the one or more microorganism (s) to be detected.
- the direct or indirect detection can be done in situ on the capture medium after, for example, addition of a revelation system.
- the analysis of said capture and concentration support is done after separation of the capture / concentration device and / or said capture / concentration support of the container.
- the analysis of the capture / concentration support can also be carried out ex situ by transferring the device and / or the capture / concentration support into an analysis device.
- the microorganisms coupled to the capture / concentration support are lysed in order to recover the nucleic acids and then analyzed by an amplification method such as PCR.
- the method according to the present invention also makes it possible to carry out sterility checks in particular within the food and environmental samples.
- generic means for detecting microorganisms such as capture supports functionalized with generic anti-Gram-, anti-Gram + type binding partners, are used as means of analysis. etc.
- the type of analysis carried out with the process of the invention can therefore be not only qualitative (detection and identification of specific micro-organism (s)) but also quantitative or semi-quantitative.
- FIG. 1 schematically represents a container according to the invention, the capture / concentration device being outside the container,
- FIG. 2 schematically represents a device with a container, a pressure means on the fluid guide for trapping a given volume of sample in the fluid guide, and a displacement means for generating the displacement of the sample contained in FIG. in the fluidic guide to the capture and / or concentration device.
- FIGS. 3, 4 and 5 are intended to illustrate the device as represented in FIG. 2 during the various steps of bringing the displacement means and the pressure means into contact with the container, thus generating the displacement of the sample contained in the guide fluidic towards the capture device and / or concentration.
- Figure 6 shows a cartridge according to the invention, the cartridge being open.
- Figure 7 illustrates a cartridge according to the invention, the cartridge being closed.
- Figure 8 shows a cartridge holder according to the invention.
- Figure 9 shows a base and a fluid guide according to the invention.
- FIG. 10 shows a cartridge inserted in a cartridge holder according to a fluidic path called "capture / concentration", the first intake duct of the cartridge holder being in fluid connection with the intake duct of the cartridge, the duct discharging the cartridge holder being in connection with the discharge path of the cartridge thus allowing the liquid sample to enter the reaction module and leave it.
- FIG. 11 shows a cartridge inserted into a cartridge holder according to a fluidic pathway called "lysis and / or washing and / or elution", the second intake duct of the cartridge holder being in fluidic connection with the intake duct. of the cartridge, the exhaust duct of the cartridge holder being in connection with the discharge path of the cartridge thus allowing the lysis liquid and / or washing to enter the reaction module and to leave.
- Fig. 12 is a schematic illustration of a cartridge holder attached to the outer wall of a container.
- the device for preparing a sample (1) represents a container (3) comprising a capture / concentration device (99) fixed to the external wall which can be disconnected.
- This container (3) has a wall (30) flexible, possibly transparent, through which have been moved an inlet port (31) and an outlet (33).
- an inlet fluid guide (32) guides the sample (4) of the container to the inlet port (31) and then to the capture and / or concentration device (99).
- the sample passes through the capture / concentration holder (104) and then passes through the outlet port (33) through the flexible wall (30) into the interior of the container.
- the capture and / or concentration device comprises at least two connectors (34) and (35) adapted to the inlet and outlet ports of the container. These two connectors are pressure-resistant and sealed to prevent the sample from spilling out of the container and thereby contaminating the environment or the technician handling the sample.
- Figure 2 shows a device (5) comprising a container (1) positioned within the device (5), in a location (57) provided for this purpose.
- This location (57) is delimited on one side by the fixed wall (52) and on the other by means of displacement represented by a first and second movable arm (similar to two blades) (53) and (56) .
- One of the roles of the arms is to homogenize, to mix the sample.
- the arms can move against the direction and / or in opposition of phase (alternation of phase).
- a pressure means (6) is associated with one of the blades to exert pressure on the fluid guide (32) through the flexible wall of the container.
- the container and the fluid guide abut against the fixed wall.
- the pressure means by crushing the fluid guide at the distal end of the inlet port against the fixed wall, traps a specific volume of sample in the fluid guide.
- the fluidic guide is an elastic tube. It may be a thin silicone tube to reduce the crushing force but with elastic property allowing a return to its initial geometry.
- the volume control means corresponds to the diameter and the length of the tube.
- the diameter and length of the tube must be defined in order to have an optimized sample volume passing through the capture medium.
- the diameter and length of the tube will also be defined according to the pressure exerted on the tube in order to establish an optimized flow through the capture medium.
- the displacement means (53) and (56) also cause the displacement of the sample contained in the fluid guide towards the capture and / or concentration device.
- the pressing means (6) can be replaced by applicators of various shapes, provided that they are capable of exerting certain force to press the fluid guide against the fixed wall, the fluidic communication of the sample from outside the guide towards the inside of the guide is thus blocked.
- the pressure means is a protuberance attached to the blade (53).
- FIG. 2 represents only a part of a device according to the invention.
- the device (5) is provided with a base (51) on which a wall (52) has been fixed.
- the two blades (53) and (56) are removable relative to the base (51).
- the movement of said arms (53) and (56) relative to the base (51) can be generated by any suitable means, such as an electric motor.
- Figures 3 to 5 show the device (5) in operation at different stages.
- the arm (53) is in a position remote from the container, indicated by the line (63), and the arm (56) is in a closer position indicated by the line ( 62).
- the distance between the arm (53) and the container does not allow the pressure means (6) to press the fluid guide.
- the arm (53) moves to a position close to the indicated container by means of the line (61), the force exerted by the pressure means (6) on the fluid guide (32) presses on the fixed wall (52) causes the pinch of the fluid guide, trapping a sample volume within it.
- the arm (53) moves to a position even closer to the indicated container by means of the line (60), the pressure means (6) retracts and the arm (53) comes into contact with the container causes the displacement of the sample volume contained in the fluid guide to the capture device and / or concentration.
- the capture and / or concentration device is brought into contact with the microorganisms from the biological sample to be analyzed and, if the target bacteria are present among the said microorganisms, the latter bind to their specific binding partner. present at said capture device and / or concentration, for example to a functionalized antibody.
- the target bacteria are then (immuno) concentrated at the level of the capture and / or concentration device and can be identified in situ, for example by immuno-detection techniques well known to those skilled in the art, implementing systems revelation as well known to this one.
- the identification step is performed outside the container, for example by implementing a VIDAS ® type automaton.
- the biological sample (4) can be any sample for which the user wishes to control the presence of microorganisms of interest.
- the sample may be of food, environmental or clinical origin (non-exhaustive list) and the microorganisms sought may be pathogenic micro-organisms, for example of the Salmonella or E. coli type.
- the assembly formed by the device (5) and the container (1) can, for example, be incubated inside an incubator (not shown).
- the conditions can be optimized within said incubator to allow growth of the desired microorganisms.
- Features, such as temperature can be adjusted to be optimal for promoting the growth of target microorganisms.
- the assembly formed of the device (5) and the container (1), positioned in the location (57) is introduced into the incubator, the operation of the arms (53) and (56) can be activated.
- the arms (53) and (56) are movable from their first position (63) to their second position (62) (and vice versa). This movement makes it possible to exert a force on the outer surface of the flexible wall of the container (1) and thus to impose on said container (1) a deformation of this flexible wall. At this stage, the arms (53) and (56) can be used to homogenize the contents of the container (1).
- the arms (53) and (56) can be moved periodically.
- the frequency can be chosen and adapted to the type of sample and / or the type of culture medium present inside the container (1).
- the arm on which the pressure means (6) is attached may move to a closer position, as explained above. Indeed, an advantageous embodiment is to delay the contacting of the sample with the capture device and / or concentration without waiting for the end of the incubation.
- This incubation phase extends, for example, over 24 hours during which the concentration of target microorganisms will gradually increase.
- the concentration of target microorganisms is too low to interact with the capture and / or concentration medium.
- the capture and concentration support (104) is brought into contact with the sample (4) by the action of the pressure means on the fluid guide and displacement means which push the sample towards the capture device.
- the sample passes into the capture medium in a tangential flow before exiting through the outlet (33) into the container (3).
- the pressure means and the moving means are moved away from the container to allow the fluid guide to resume its original shape.
- the cycle can begin again, the pressure means can again pinch the fluid guide and the moving means can move the sample volume trapped in the fluid guide to the capture device.
- the repeated circulation of the sample through the capture medium makes it possible to increase the efficiency of the capture of the target microorganisms.
- the technician can read the result of the analysis on the capture / concentration support through the capture / concentration device (99).
- the cartridge (100) as shown in Figure 6 comprises a cover (101) and a bottom (102) assembled by clips (103) for sealing.
- the capture medium (104) is disposed within the reaction module (105) of the cartridge.
- the capture medium is a membrane.
- the cartridge includes:
- FIG. 7 is a bottom view of the cartridge shown in Figure 6.
- the cartridge (100) is in the closed position, the bottom (102) and the cover (101) are assembled through clips (103).
- the outer face of the bottom (102) includes slides (106) serving as insertion means for the cartridge to be inserted into a cartridge holder.
- the slides can also play the role of foolproof.
- the cartridge includes:
- an escape route (202) for the liquid sample and / or the washing liquid and / or the lysis liquid and / or the elution liquid An oblong boss (203) widens the escape route.
- the capture and / or concentration support (104) (not visible in FIG. 2) is disposed inside the cartridge between the intake path (201) and the escape route (202) so that all or part of the sample or liquids passes through it.
- a first intake duct (301) allowing the entry of a liquid sample
- a second intake duct (303) allowing the entry of a washing liquid and / or a lysis liquid; and or an elution liquid
- the means of insertion of the cartridge holder can also play the role of polarizing and avoids the accidental removal. It is represented here by slides (304).
- the cartridge holder (300) is intended to be attached to the outer face of the wall of the container.
- the base (400) as shown in Figure 9 is intended to be contiguous to the inner face of the container wall.
- the base (400) is connected to a fluid guide (32) allowing the sample contained in the container to reach the intake channel of the base (401).
- FIG. 10 shows the cartridge (100) disposed in the cartridge holder (300) according to a so-called "capture / concentration" fluidic path.
- the intake path (201) (shown in FIG. 7) of the cartridge is in fluid connection with the first intake duct
- the escape route (202) (shown in FIG. 7) of the cartridge is in connection with the discharge duct of the cartridge holder
- a translational movement of the cartridge in the cartridge holder following the slides (304) makes it possible to go from a so-called “capture / concentration” fluidic path to a fluidic path called "lysis and / or washing and / or elution ".
- FIG. 11 shows the cartridge (100) disposed in the cartridge holder (300) according to a fluidic pathway called "lysis and / or washing and / or elution".
- the inlet channel (201) (shown in FIG. 7) of the cartridge is in fluid connection with the second intake duct (303) (represented in FIG. 8) of the cartridge holder.
- the escape route (302) (shown in FIG. 7) of the cartridge is connected with the discharge duct (202) (shown in FIG. 3) of the cartridge holder thus allowing the lysis liquid and / or washing and / or elution to enter the reaction module and come out.
- the escape route (202) (shown in FIG. 7) of the cartridge is in connection with the exhaust duct (302) (shown in FIG. cartridge holder due to the presence of an oblong boss (203) (shown in Figure 7) on the cartridge.
- the cartridge holder (300) is fixed to the outer face of the wall of the container (3) as shown in Figure 12.
- the cartridge can be inserted into the cartridge holder.
- the container may contain a fluid guide which guides the sample of the container to the intake channel of the base and then the first inlet duct of the cartridge holder and the inlet path of the cartridge.
- the sample passes through the capture / concentration holder and then passes through the cartridge discharge path, the cartridge holder exhaust duct, and the base evacuation channel to return to the container.
- the capture device and / or concentration is brought into contact with the microorganisms from the biological sample to be analyzed and, if the target bacteria are present among said microorganisms, they bind to their specific binding partner present in the level of said capture device and / or concentration, for example to a functionalized antibody.
- the sample passes into the capture medium in a tangential flow before exiting via the evacuation path into the container.
- the repeated circulation of the sample through the pasture support and / or concentration makes it possible to increase the efficiency of the capture of the target microorganisms.
- Example 1 The functionality of the invention is illustrated with the example (non-limiting) presented below.
- Example 1 The functionality of the invention is illustrated with the example (non-limiting) presented below.
- biosensor 550 ⁇ membranes (Reemay 2040) functionalized
- Adiafood Extraction Kit XT1 and XT2 Reagent (Cat No. ADIF9988) 1.5 mL eppendorf tube dry bath set at 120 ° C
- EPT Peptone Water
- the capture medium is polyester, marketed by PGI (Cat No. Reemay 2040).
- the product is cut into a slice of 4 cm 2 (1 cm X 4 cm).
- BSA Bovine Albumin Serum
- the support is then immersed at 37 ° C. for two hours in a streptavidin solution at 10 ⁇ g / ml
- the support is then immersed for two hours at 37 ° C. in a solution of specific binding partners (1 ⁇ g / ml at 40 ⁇ g / ml, the specific binding partner being a recombinant phage protein against Salmonella).
- the sensitized carrier thus produced can be used for the detection of microorganisms or stored at 2-8 ° C for later use.
- Preparation of the food sample 375 g of food sample (ground steak 15% fat) are weighed in the plastic bag containing the present invention, then 1000 ml of enrichment medium (EPT) and 5 ml of tween 80 are added.
- EPT enrichment medium
- the plastic bag is directly incubated at 39 ° C in the device described in the patent application WO2014072438 filed by the applicant implementing a gentle homogenization of the sample for 5 hours of incubation.
- a membrane functionalized with the anti Salmonella phage protein (SLM membrane) is used as a capture medium (Bagflow sample called B +).
- An SLM membrane is also immersed. She will be in soaking.
- the bags are homogenized for 5 min (the time that the strain is distributed homogeneously in the bag) before starting the capture cycle.
- the circulation sequence lasts 30 minutes at 2 mL / min, or 60 mL of sample passes through the capture device.
- the contact time is 30 minutes under stirring.
- the pre-enriched food sample for 5 hours is divided into 5 aliquots of 9 mL.
- the aliquots are artificially contaminated with the Salmonella strain at a concentration ranging from 4 to 10 7 CFU / mL. This range makes it possible to compare the sensitivity gain between the present invention and the existing method.
- the samples undergoing the process according to the invention exhibit a capture / concentration efficiency one log higher than the soaking sample. Indeed, a difference of 3 Ct is observed between the results (B +) and soaking (T +). It is thus demonstrated that circulating the sample through the mesh of the membrane improves the probabilities of capture, between the phage proteins and the bacteria of interest.
- the GeneUp qPCR reference method gives a positive result from 10 5 CFU / mL.
- the capture / concentration method thus makes it possible to gain at least 3 log of sensitivity on the detection method.
- This example shows the significant gain of the capture / concentration with the device according to the present invention, compared to a simple dipping of the membrane in the sample.
- the detection limit of the method is clearly close to 20 CFU / mL, which considerably reduces the enrichment time and therefore the analysis time. In fact, this level of detection makes it possible to give a positive response to a sample of 375 g of contaminated food matrix at 1 CFU, in less than 5 hours of incubation.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Sustainable Development (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Clinical Laboratory Science (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
Claims
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1659745A FR3057275B1 (fr) | 2016-10-10 | 2016-10-10 | Procede et dispositif de preparation d'echantillons. |
| FR1659746A FR3057276B1 (fr) | 2016-10-10 | 2016-10-10 | Procede et dispositif de capture et/ou concentration de microorganisme. |
| PCT/FR2017/052755 WO2018069612A1 (fr) | 2016-10-10 | 2017-10-09 | Procédé et dispositif de préparation d'échantillons |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP3523624A1 true EP3523624A1 (fr) | 2019-08-14 |
| EP3523624B1 EP3523624B1 (fr) | 2024-03-27 |
Family
ID=60262945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP17794362.8A Active EP3523624B1 (fr) | 2016-10-10 | 2017-10-09 | Procédé et dispositif de préparation d'échantillons |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US12024702B2 (fr) |
| EP (1) | EP3523624B1 (fr) |
| ES (1) | ES2981688T3 (fr) |
| WO (1) | WO2018069612A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202200022533A1 (it) * | 2022-11-03 | 2024-05-03 | Mirco Cavicchioli | Dispositivo attivatore di un materiale agglomerato e rispettivi kit e procedimento di selezione |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3963355A (en) * | 1972-05-22 | 1976-06-15 | Mcdonnell Douglas Corporation | Process and apparatus for analyzing specimens for the presence of microorganisms therein |
| US5976824A (en) * | 1993-11-24 | 1999-11-02 | Abbott Laboratories | Method and apparatus for collecting a cell sample from a liquid specimen |
| DE19707497A1 (de) * | 1996-08-16 | 1998-02-19 | Boehringer Mannheim Gmbh | Reaktionsbeutelvorrichtung zur Durchführung von mehrstufigen Kultivierungs/Separations-Vorgängen und/oder Reaktionen |
| DE19806780C1 (de) | 1998-02-18 | 1999-07-01 | November Ag Molekulare Medizin | Vorrichtung zur Isolierung und Aufreinigung von Nukleinsäuren |
| FR2853326B1 (fr) | 2003-04-07 | 2005-05-06 | Biomerieux Sa | Procede de detection et/ou d'identification de bacteries presentes dans un echantillon |
| ES2660180T3 (es) * | 2007-12-07 | 2018-03-21 | Miltenyi Biotec Gmbh | Sistemas y métodos para procesamiento de células |
| US9550970B2 (en) * | 2010-02-17 | 2017-01-24 | Inq Biosciences Corporation | Culture systems, apparatus, and related methods and articles |
| US9028777B2 (en) | 2010-03-23 | 2015-05-12 | Fluidigm Corporation | Automated cellular material preparation |
| US20130071872A1 (en) * | 2011-09-15 | 2013-03-21 | Lewis Ho | Device and method for single-used matrix sampling |
| FR2997703B1 (fr) | 2012-11-07 | 2016-12-30 | Biomerieux Sa | Procede de traitement d'au moins un echantillon biologique |
| US10697871B2 (en) * | 2016-10-07 | 2020-06-30 | Massachusetts Institute Of Technology | Particle isolation/enrichment using continuous closed-loop micro-fluidics |
-
2017
- 2017-10-09 EP EP17794362.8A patent/EP3523624B1/fr active Active
- 2017-10-09 ES ES17794362T patent/ES2981688T3/es active Active
- 2017-10-09 WO PCT/FR2017/052755 patent/WO2018069612A1/fr not_active Ceased
- 2017-10-09 US US16/336,441 patent/US12024702B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20200024569A1 (en) | 2020-01-23 |
| WO2018069612A1 (fr) | 2018-04-19 |
| ES2981688T3 (es) | 2024-10-10 |
| EP3523624B1 (fr) | 2024-03-27 |
| US12024702B2 (en) | 2024-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1154847C (zh) | 检测污染物的方法和装置 | |
| JP6470375B2 (ja) | 微生物培養試料中の微生物を検出および同定するための方法、システムならびにデバイス | |
| US10774300B2 (en) | Methods and kits for isolating microorganisms from culture | |
| EP3209793B1 (fr) | Methode et dispositifs de traitement d'echantillons biologiques | |
| WO2014072438A1 (fr) | Procédé de traitement d'au moins un échantillon biologique | |
| US10119965B2 (en) | Portable enrichment, aliquoting, and testing device of microorganisms and toxins | |
| FR3027678A1 (fr) | Procede de detection d'organismes dans un echantillon dilue | |
| FR3025315A1 (fr) | Dispositif d'obtention de matiere biologique et/ou d'information biologique a partir d'un echantillon a matrice heterogene | |
| WO2009122069A1 (fr) | Procede de detection en temps reel de microorganismes dans un milieu de culture liquide par agglutination | |
| EP2802875B1 (fr) | Procede de detection et d'identification directe par voie optique d'un microorganisme dans un echantillon biologique | |
| CN1768150A (zh) | 用于检测和/或鉴定样品中存在的细菌的方法 | |
| EP2872867B1 (fr) | Systeme automatise de lyse de microorganismes presents dans un echantillon, d'extraction et de purification des acides nucleiques desdites microorganismes aux fins d'analyse | |
| WO2016062974A1 (fr) | Méthode de traitement d'échantillons biologiques, notamment d'échantillons alimentaires | |
| US20240043941A1 (en) | Systems, methods, and apparatuses for concentration and identification of a microorganism from blood | |
| EP3523624B1 (fr) | Procédé et dispositif de préparation d'échantillons | |
| EP2802874A1 (fr) | Procede pour capturer et concentrer un microorganisme dans un echantillon biologique | |
| FR3057275A1 (fr) | Procede et dispositif de preparation d'echantillons. | |
| FR3057276A1 (fr) | Procede et dispositif de capture et/ou concentration de microorganisme. | |
| JP3973876B2 (ja) | 新規の細菌分析方法 | |
| CN120098782A (zh) | 一种用于检测沙门氏菌的微流控装置及检测方法 | |
| FR2674632A1 (fr) | Procede et dispositif de detection rapide de micro-organismes indesirables dans un produit du domaine agro-alimentaire ou medico-veterinaire. | |
| RU2006104588A (ru) | Способ определения зараженности продовольствия патогенными биологическими агентами при лабораторном контроле |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20190318 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20230503 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
| INTG | Intention to grant announced |
Effective date: 20231025 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602017080404 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: FRENCH |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 |
|
| REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240628 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240627 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240627 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240627 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240628 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20240327 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1670352 Country of ref document: AT Kind code of ref document: T Effective date: 20240327 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240727 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2981688 Country of ref document: ES Kind code of ref document: T3 Effective date: 20241010 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240729 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240729 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240727 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602017080404 Country of ref document: DE |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| 26N | No opposition filed |
Effective date: 20250103 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240327 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20241009 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20241031 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20241031 |
|
| REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20241031 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20241009 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20251029 Year of fee payment: 9 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20251027 Year of fee payment: 9 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20251021 Year of fee payment: 9 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20251027 Year of fee payment: 9 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20171009 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20251103 Year of fee payment: 9 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20171009 |